Loading…
GSK
GSK plc
NYSE· Healthcare· Drug Manufacturers - General· CUSIP 37733W204
$51.21+2.38%Price as of Oct 23, 00:45 UTC · updated once a day, after the close
At a glance
GSK plc (GSK) is listed on NYSE and classified in Drug Manufacturers - General, part of the Healthcare sector. It is headquartered in London, United Kingdom and has 66,841 employees. The company is worth $102.6B and trades at 15.8x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was £32.67B in fiscal 2025, up 4.1% from the year before. Net income was £5.72B. The share price is 17.0% below its 52-week high of $61.70. It pays a dividend yielding 3.55%. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Steve Cohen (Point72 Asset Management), at $139.06M. In that quarter, 4 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $102.6B
- P/E
- 15.8x
- Forward P/E
- 10.4x
- P/B
- 4.3x
- Dividend yield
- 3.55%
- Payout
- 56.00%
- EPS
- $3.25
- ROE
- 33.38%
- Profit margin
- 14.52%
- Revenue growth
- +5.30%
- Beta
- 0.28
- 52-week high
- $61.70
- 52-week low
- $42.85
History
Year by year, from the annual reports; dividends from the payments themselves.
Revenue, debt and profit are in GBP, the currency the company reports in — not converted to dollars. Dividends are in dollars.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▲ +20.4% over 5Y.
today you would have $1,431.96▲ +43.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $49.04 | $33.82 | $37.06 | $35.14 | |
| EPS | £2.78 | £1.24 | £2.40 | £7.32 | |
| Dividend yield | 4.18% | 3.42% | 4.60% | 3.75% | 4.78% |
| Profit margin | 16.87% | 17.50% | 8.21% | 16.25% | 51.00% |
| ROE | 35.91% | 34.90% | 18.84% |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
$29.37
Square root of 22.5 × earnings × book value. Blind to intangibles, so it undervalues software and brands.
Earnings
$11.55
Earnings growing 0.0% a year plus a 3.6% dividend yield. Growth capped at 25%.
Earnings
$78.93
Median P/E of 24.3 among peers in the sector.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
$23.93
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| HCAHCA Healthcare, Inc. | $467.31 | 15.4x | — | 0.67% | — | $101.17B |
| SNYSanofi | $41.96 | 22.1x | 1.3x | 5.77% | 5.71% | $100.54B |
| ELVElevance Health, Inc. | $445.28 | 18.4x | 2.2x | 1.55% | 11.13% | $96.57B |
| SYKStryker Corp | $307.08 |
About the company
- 66,841
- London, United Kingdom
